Recent advances in vaccine and immunotherapy for COVID-19
AA Rabaan, SH Al-Ahmed, R Sah… - Human vaccines & …, 2020 - Taylor & Francis
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and
hundreds of thousands of deaths. Beyond there being no available antiviral therapy …
hundreds of thousands of deaths. Beyond there being no available antiviral therapy …
Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects
Z Zhang, Q Shen, H Chang - Frontiers in immunology, 2022 - frontiersin.org
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …
Immunological considerations for COVID-19 vaccine strategies
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
[HTML][HTML] Progress and challenges in the development of COVID-19 vaccines and current understanding of SARS-CoV-2-specific immune responses
KD Kim, I Hwang, KB Ku, S Lee, SJ Kim… - Journal of microbiology …, 2020 - ncbi.nlm.nih.gov
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared …
syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared …
[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …
century. In 11 months since its first emergence, according to WHO, the causative infectious …
Viral targets for vaccines against COVID-19
L Dai, GF Gao - Nature Reviews Immunology, 2021 - nature.com
Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19)
pandemic and to help the return to pre-pandemic normalcy. A great many vaccine …
pandemic and to help the return to pre-pandemic normalcy. A great many vaccine …
Vaccines for COVID-19
JS Tregoning, ES Brown… - Clinical & …, 2020 - academic.oup.com
Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019,
there has been an explosion of vaccine development. By 24 September 2020, a staggering …
there has been an explosion of vaccine development. By 24 September 2020, a staggering …
Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
SA Hosseini, F Zahedipour, H Mirzaei… - International …, 2021 - Elsevier
Since September 2020, the world has had more than 28 million cases of coronavirus
disease 2019 (COVID-19). Many countries are facing a second wave of the COVID-19 …
disease 2019 (COVID-19). Many countries are facing a second wave of the COVID-19 …
Pharmaceutical aspects and clinical evaluation of COVID-19 vaccines
ABSTRACT COVID-19, the disease caused by the novel severe acute respiratory syndrome-
associated coronavirus 2 (SARS-CoV-2), was first detected in December 2019 and has …
associated coronavirus 2 (SARS-CoV-2), was first detected in December 2019 and has …
[HTML][HTML] The immunology of SARS-CoV-2 infections and vaccines
L Grigoryan, B Pulendran - Seminars in immunology, 2020 - Elsevier
Abstract SARS-CoV-2, the virus that causes COVID-19, emerged in late 2019, and was
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …